期刊文献+

真核细胞表达单纯疱疹病毒Ⅰ型包膜糖蛋白B及其抗原性与免疫原性分析

Expression of Herpes Simplex Virus Type Ⅰ Glycoprotein B in Eukaryotic Cells and Analysis of Its Antigenicity and Immunogenicity
原文传递
导出
摘要 为在真核细胞中表达并纯化I型单纯疱疹病毒(HSV I)包膜糖蛋白gB,并分析其抗原性和免疫原性,化学合成了包膜糖蛋白gB1胞外区基因片段,构建真核表达载体,并转染至HEK293细胞,表达的蛋白用羊抗HSV1+HSV2血清作为一抗,用ELISA检测其抗原性;用纯化的gB1蛋白免疫昆明小鼠,观察诱发抗体产生的时间及其效价,并用ELISA和Western blot检测小鼠抗gB1多克隆抗体特异性识别重组gB1抗原的能力,评价其免疫原性。结果显示在HEK293细胞中成功表达重组gB1蛋白,ELISA证实羊抗HSV1+HSV2多抗能够识别重组gB1蛋白;重组gB1蛋白免疫小鼠7周后,小鼠血清中多克隆抗体效价达到5×103,表明在真核细胞中高效表达并纯化的重组gB1蛋白具有良好的抗原性和免疫原性,为HSV检测试剂和疫苗研究提供了理论基础。 To express and purify herpes simplex virus type I(HSV I)glycoprotein B(gB)in eukaryote cells with the purpose of analyzing the antigenicity and immunogenicity.At the beginning,the extracellular domain fragment gene of gD1 was synthesized by chemical method and cloned into eukaryotic expression vector pCEP4 to construct the recombinant plasmid pCEP4-gD1.After transfection of HEK293 cells with the recombinant plasmid,the expressed protein was characterized by Western blot and purified through Ni affinity chromatography.Then antigenicity of the protein was detected by ELISA.Finally,the purified protein was used to immunize Kunming mice in 1,3,5 weeks respectively,and antiserum were collected in 3,5 and 7 weeks.The antibody titer was detected by indirect ELISA for immunogenicity analysis.Gene sequencing analysis demonstrates that the recombinant plasmid pCEP4-gB1 was constructed successfully.Western blot analysis indicated one major protein band,which molecular weight is approximate 85 kDa corresponding to the truncated forms of gB1 protein,was observed.In addition,ELISA detection showed that expressed gB1 has good antigenicity.After the third immunization,antibody titer of the mouse anti-gB1 was 5×103.The successful expression of the recombinant protein gD1,which can induce humoral immune response,lays a foundation for serological diagnosis and vaccine study of HSV.
出处 《中国生物工程杂志》 CAS CSCD 北大核心 2010年第6期8-13,共6页 China Biotechnology
基金 国家"863"计划资助项目(2006AA02A226)
关键词 单纯疱疹病毒 包膜糖蛋白gB1 真核表达 抗原性 免疫原性 Herpes simplex virus Type I(HSV I) Glycoprotein B Eukaryotic cell expressionAntigenicity Immunogenicity
  • 相关文献

参考文献23

  • 1Eizuru Y. Development of new antivirals for herpesviruses. Antivir Chem Chemother, 2003, 14 (6) :299-308.
  • 2Wald A, Link K. Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a metaanalysis. J Infect Dis, 2002, 185(1) :45-52.
  • 3Perez G, Skumick J H, Denny T N, et al. Herpes simplex type Ⅱ and Mycoplasma genitalium as risk factors for heterosexual HIV transmission: report from the heterosexual HIV transmission study. Int J Infect Dis, 1998, 3(1) :5-11.
  • 4Chen C Y, Ballard R C, Beck-Sague C M, et al. Human immunodeficiency virus infection and genital ulcer disease in South Africa: the herpetic connection. Sex Transm Dis, 2000, 27 ( 1 ) : 21-29.
  • 5Langenberg A G M, Burke R L, Adair S F, et al. A recombinant glycoprotein vaccine for herpes simplex type2 : safety and efficacy. Ann Intern Med, 1995, 122(12):889-898.
  • 6杨慧兰,周翠,关蕾,赵举峰,樊建勇.单纯疱疹病毒II型CTL表位DNA疫苗的Th1/Th2免疫应答研究[J].中国皮肤性病学杂志,2007,21(7):402-404. 被引量:5
  • 7吕敏,潘明洁,杨华凤,李越希.单纯疱疹病毒1型糖蛋白B胞外区基因片段的克隆、表达及初步鉴定[J].药物生物技术,2008,15(2):90-93. 被引量:1
  • 8Ashley R L, Wald A. Genital herpes: review of the epidemic and potential use of type-specific serology. Clin Microbiol Rev, 1999, 12(1):1-8.
  • 9Stanberry L, Cunningham A, Mertz G, et al. New developments in the epidemiology, natural history, and management of genital herpes. Antiviral Res, 1999, 42(1) :1-14.
  • 10Fleming D T, McQuillan G M, Johnson R E, et al. Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med, 1997, 337(16) :1105-1111.

二级参考文献18

  • 1关蕾,杨慧兰,樊建勇.单纯疱疹病毒Ⅱ型细胞毒性T淋巴细胞表位重组DNA疫苗的构建表达及鉴定[J].临床皮肤科杂志,2006,35(6):351-353. 被引量:3
  • 2Stanberry LR, Jorgensen BM, Nahmias AJ. Herpes simplex viruses 1 and 2. In: Evand AS, koslow RA, editors. Viral infections of humans : epidemiology and control [M]. 4th ed. New York: plenum Medical Book Company 1997, 419.
  • 3Nahmias AJ, Bannenbarger J, Wickliffe C, et al. Clinical aspects of infection with herpes simplex viruses 1 and 2[M]. In Nahmias A J, BowBle WR, Schinazi RE:The human herpes viruses :An Interdisciplinary persoective Elsevier Press, Amsterdam 1980,3.
  • 4Richard JW, Kaiwar R, Nesburn AD, etal. Herpes simplex virus infections[J]. Lantet 2001,357:1513.
  • 5Baghian A, Chouljenko VN, Dauvergne O, et al. Protective immunity against lethal HSV-1 challenge in mice by nucleicacid-based immunization with heropes simlex virus type-1 genes specifying glycoproteins gB and gD[J].J Med Microbiol, 2002,51(4) :350.
  • 6Stanberry LR. Glycoprotein-D-adjuvant vaccine to prevent genital herpes[J]. N Engl J Med,2002,347:1652.
  • 7Manservigi R, Boero A, Argnani R, etal. Immunotherapeu tic activity of a recombinant combined gB-gD-gE vaccine against recurrent HSV2 infections in a guinea pig model[J]. Vaccine, 2005, 23(7):865.
  • 8Orr MT, Orgun NN, Wilson CB, et al. Cutting Edge: Recombinant Listeria monocytogenes expressing a single irnmune-dominant peptide confers protective immunity to herpes simplex virus- 1 infection[J]. J Immunol, 2007,178(8) :4731.
  • 9Bamdad T, Roostaee MH, Sadeghizadeh M, et al. Immuno genicity and protective effect of a DNA construct encoding certain neutralizing epitopes of herpes simplex virus type-1 glycoprotein B[J]. Folia Biol (Praha), 2005,51(4) : 109.
  • 10Pellett PE, Kousoulas KG, PereiraL, et al. Anatomy of the her pes simplex virus I strain F glycoprotein B gene: primary sequence and predicted protein structure of the wild type and of monoclonal antibody-resistantmutants[J]. J Virol , 1985,53(1):243.

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部